HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and immunopathological studies of pars planitis in a family.

Abstract
We examined a family in which two brothers with identical HLA typing have pars planitis with snowbanking. Immunopathological studies of one of their eyes showed that in the area of snowbanking over the pars plana there was mild to moderate inflammatory cell infiltration, consisting of mostly Pan T (Leu 4+) lymphocytes. The ratio of T helper/inducer to T suppressor/cytotoxic cells was approximately 10:1. Few macrophages (OKM1+) were identified. Very few B cells and no NK cells were observed. Some retinal vessels had a perivascular infiltration consisting of mostly T lymphocytes. Most of the inflammatory cells bore class II antigens (HLA-DR+), while T cells bore few IL-2 receptors (anti-TAC+). The snowbank consisted mainly of glial elements (GFAP+) and basement membrane components (type IV collagen and laminin) with the predominant cell the Müller cell (Mü+). A site of inflammation at the iris-ciliary body junction also stained for B cells (Leu 14+). These findings suggest that the snowbank could be formed by the glial elements of the peripheral retina. The chronic inflammation in pars planitis appears to consist of helper T cells, both in the pars plana, and the retinal vasculature.
AuthorsR P Wetzig, C C Chan, R B Nussenblatt, A G Palestine, D O Mazur, K K Mittal
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 72 Issue 1 Pg. 5-10 (Jan 1988) ISSN: 0007-1161 [Print] England
PMID3257703 (Publication Type: Case Reports, Journal Article)
Chemical References
  • HLA Antigens
  • HLA-DR Antigens
Topics
  • Adolescent
  • Adult
  • Ciliary Body (immunology)
  • HLA Antigens (analysis)
  • HLA-DR Antigens (analysis)
  • Humans
  • Iris (immunology)
  • Leukocyte Count
  • Male
  • Retinal Vessels (immunology)
  • T-Lymphocytes (immunology)
  • Uveitis, Anterior (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: